Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07184632 · ClinicalTrials.gov registry record · Phase 2

A Research Study on How Well Different Doses of the Medicine NNC0662-0419 Help People Living With Overweight or Obesity

A Phase 2 study of Obesity and Overweight, sponsored by Novo Nordisk A/S.

Recruiting
Registry status
Phase 2
Development phase
220
Enrollment target
2
Study locations

NCT07184632 is a Phase 2 study of Obesity and Overweight that is actively recruiting participants, run by Novo Nordisk A/S. The registered enrollment target is 220 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (73% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07184632, a Phase 2 study of Obesity and Overweight, is actively recruiting participants, sponsored by Novo Nordisk A/S.

RECRUITING
Registry status
Phase 2
Development phase
220 participants
Enrollment target
2
Study locations

Study Summary

This study tests how well different doses of the medicine NNC0662-0419 help people living with overweight or obesity. The purpose of the study is to find out if NNC0662-0419 is safe and effective for treating people living with overweight or obesity. There are 2 study treatments in this study, participants will get either NNC0662-0419, the treatment being tested or placebo, a treatment that has no active medicine in it. NNC0662-0419 is a new medicine which cannot be pre-scribed by doctors but has previously been tested in humans.

Conditions Studied

Obesity Overweight

Interventions

  • DRUG Placebo
  • DRUG NNC0662-0419

Study Locations (2)

Arizona

  • Celerion, Phoenix - Tempe

Nebraska

  • Celerion, Lincoln - Lincoln

Trial Details

FieldValue
Enrollment Target 220 participants
Start Date 2025-10-01
Est. Completion 2026-12-01
Phase Phase 2

Sponsor

Novo Nordisk A/S

431 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT07184632

The ClinicalTrials.gov registry entry for NCT07184632 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 220 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (73% lower). The listed sponsor is Novo Nordisk A/S, which has 431 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Obesity appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT07184632 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Arizona, Nebraska.

Frequently Asked Questions

What is clinical trial NCT07184632 about?

NCT07184632 is a clinical study titled "A Research Study on How Well Different Doses of the Medicine NNC0662-0419 Help People Living With Overweight or Obesity". This study tests how well different doses of the medicine NNC0662-0419 help people living with overweight or obesity. The purpose of the study is to find out if NNC0662-0419 is safe and effective for treating people living with overweight or obesity. There are 2 study treatments in this study, parti...

What is the current status of trial NCT07184632?

This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 220 participants. The study started on 2025-10-01. Estimated completion is 2026-12-01.

What conditions does trial NCT07184632 study?

This clinical trial studies the following conditions: Obesity, Overweight.

What interventions are being tested in trial NCT07184632?

The interventions under investigation include: Placebo (DRUG), NNC0662-0419 (DRUG).

Who is sponsoring clinical trial NCT07184632?

This trial is sponsored by Novo Nordisk A/S, which has 431 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07184632 being conducted?

This trial has 2 study locations across Arizona, Nebraska. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Obesity

All registered trials for this condition

Overweight

All registered trials for this condition

Arizona

All trials with a study site in Arizona

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.